Pro Brands

Healthy Extracts Buys Imaraïs: The Ingestible Beauty Play

Healthy Extracts' $20M acquisition of Sommer Ray's Imaraïs Beauty reveals how supplement brands are using celebrity-anchored ingestible beauty lines as retail distribution wedges.

Two sleek beauty-supplement bottles in blush rose and soft pearl white positioned together with a minimalist card between them in warm golden light.

Healthy Extracts just paid approximately $20 million for Imaraïs Beauty, a gummy supplement brand co-founded by fitness influencer Sommer Ray and entrepreneur Aaron Hefter. The deal is not just a celebrity brand pickup. It's a signal about where the supplement and wellness industry is heading, and why mass retail shelf presence is now the fastest path to an exit.

If you're building or investing in a wellness brand right now, this acquisition tells you something specific about the playbook that's working in 2026.

What Healthy Extracts Actually Bought

Imaraïs Beauty sells ingestible beauty products, primarily gummies targeting skin, hair, and nail health. The brand is already placed at Ulta Beauty and Target, two of the most competitive retail environments for wellness products in the US. That retail presence alone is worth examining carefully.

Getting onto Ulta's shelves is not straightforward for an independent supplement brand. Ulta has spent the last three years aggressively expanding its wellness assortment, but it's selective. Brands need a story that bridges beauty and health, aesthetic packaging that fits the beauty aisle, and enough consumer demand signal to justify the shelf space. Imaraïs ticked all three boxes, largely because of Sommer Ray's 26-million-plus Instagram following and her credibility with a fitness-adjacent audience.

Target adds a different dimension. It's mass reach with a health-conscious shopper base that skews toward the exact consumer who blurs the line between a skincare routine and a supplement stack. Combined, these two retail doors represent a distribution footprint that would cost a challenger brand years and significant marketing spend to build organically.

The Revenue Math and What the Multiple Says

The combined entity is projecting a $24 million annualized revenue run rate post-acquisition. With the deal priced at roughly $20 million, that puts the acquisition multiple at approximately 0.83x forward revenue. That's tight.

For context, high-growth DTC wellness brands with strong unit economics and diversified customer acquisition have traded at 2x to 4x revenue in recent years. A sub-1x multiple on a brand with retail presence at Ulta and Target tells you something about the risks Healthy Extracts was pricing in.

The primary risk is celebrity dependency. Imaraïs is meaningfully tied to Sommer Ray's identity and audience. If she steps back, pivots her content focus, or faces any reputational headwinds, the brand's organic marketing engine weakens. Acquirers discount heavily for that single point of failure, which is exactly what you're seeing in this multiple.

But the flip side is also true. A brand with authentic celebrity co-founder equity, proven retail velocity, and a growing category tailwind doesn't often come available at 0.83x revenue. Healthy Extracts is betting it can systematize the brand's retail execution and reduce the dependency risk over time while keeping the social halo intact.

Ingestible Beauty: Why This Category Is Outpacing Traditional Sports Nutrition

Imaraïs operates in the ingestible beauty segment, which is growing faster than most traditional sports nutrition categories right now. Market research published in 2024 projected the global ingestible beauty market to reach $9.2 billion by 2030, growing at a compound annual rate above 12%. Sports nutrition, by comparison, is growing at roughly 7% to 8% annually in comparable markets.

The driver is consumer behavior, not just demographics. Shoppers who previously bought collagen powder from a supplement store are now picking up a skin-focused gummy from the beauty aisle. The product is the same category of ingredient. The positioning, packaging, and retail context are completely different, and that context commands a higher price point and a lower customer resistance to purchase.

This matters for the Healthy Extracts thesis. Imaraïs is not competing primarily against protein powders or creatine. It's competing against skincare serums and beauty supplements that sit on the same shelf at Ulta. That's a different competitive set with different margin dynamics and a different shopper psychology.

The fitness and wellness consumer driving this shift is increasingly the same person documented in research around Gen Z's gym identity and social media supplement culture. For that cohort, the supplement they take is part of their aesthetic identity, not just a performance tool. Ingestible beauty products are perfectly positioned to serve that behavior.

The Acquisition Playbook This Deal Fits Into

This is not an isolated transaction. It fits a clear pattern that's accelerating across the supplement and wellness space. Established brands with operational infrastructure are acquiring founder-led, influencer-anchored brands rather than building their own DTC presence from scratch.

The logic is straightforward. Building a brand today means competing for paid social attention in one of the most expensive digital advertising environments in history. Customer acquisition costs for supplement brands on Meta and TikTok have climbed steadily. A founder with a genuine fitness audience provides a built-in, low-cost acquisition channel that no paid media budget can fully replicate.

As detailed in the influencer brand acquisition playbook for 2026, acquirers are specifically targeting brands where the founder's audience is engaged and fitness-relevant rather than broadly celebrity-driven. Sommer Ray's following is built around gym culture and fitness aesthetics, which aligns tightly with Imaraïs's positioning. That's a more defensible asset than a general entertainment celebrity endorsement.

The deal also echoes the logic behind Unilever's $1.2 billion acquisition of Grüns, where a legacy consumer goods company paid a significant premium to access a supplement brand with a digitally native audience and retail presence. The Healthy Extracts play is a smaller-scale version of the same thesis: buy the audience, the shelf space, and the brand equity together rather than trying to construct them sequentially.

What Mass Retail at Ulta and Target Actually Changes

For supplement brands watching this deal, the Ulta and Target placement deserves specific attention. These two retailers represent different but complementary distribution channels that together dramatically expand a brand's addressable market.

Ulta gives Imaraïs access to a beauty-focused shopper who may have never walked into a GNC or visited a supplement-specific website. The average Ulta customer is already conditioned to spend on appearance-related products. Positioning a gummy supplement alongside skincare in that environment converts a category skeptic into a category participant.

Target adds scale and frequency. Target shoppers visit the store or app multiple times per month. Supplement repurchase behavior is naturally recurring, and Target's loyalty infrastructure supports that repeat purchase cycle better than most specialty retailers.

For independent wellness brands trying to understand what an exit looks like in 2026, this deal confirms that landing retail placement at premium or mass beauty destinations is now a direct exit accelerant. It changes your valuation conversation with potential acquirers in a way that pure DTC scale doesn't, because it demonstrates that consumers will buy your product without the founder's social media post doing the selling.

The Risks Healthy Extracts Still Needs to Manage

None of this means the deal is without execution risk. Three challenges stand out.

  • Celebrity transition risk. Sommer Ray's involvement post-acquisition will determine how much of the brand's organic social reach carries forward. Deals structured with founder equity rollover and ongoing content commitments tend to outperform clean buyouts in the first 24 months.
  • Category competition. The ingestible beauty aisle is getting crowded fast. Established supplement companies with larger marketing budgets are entering the space, and beauty incumbents like Hum Nutrition and Moon Juice already have significant retail presence and brand recognition.
  • Retail execution pressure. Ulta and Target both apply performance pressure on their supplier base. Brands that don't hit velocity thresholds lose shelf space. Healthy Extracts will need to sustain reorder rates without relying solely on Sommer Ray's social promotion.

The $24 million revenue run rate target also implies meaningful growth from the existing base. Hitting that number requires either expanding retail doors, increasing SKU count, or driving higher repeat purchase rates. Probably all three simultaneously.

What This Means for the Broader Wellness Market

The Healthy Extracts acquisition of Imaraïs is a data point in a broader restructuring of the supplement industry. The lines between sports nutrition, beauty, and wellness are dissolving at the consumer level, and the brands winning distribution are the ones positioned at those intersections rather than firmly inside a single category.

The category dynamics driving this deal are also feeding broader investment activity in the space. The GLP-1 adjacency play, loyalty infrastructure investment, and the scaling of science-backed nutrition brands are all converging in a market where consumers are spending more on health optimization than at any previous point. The strategic rationale behind Nourish's $100 million Series C and the GLP-1 brand opportunity reflects the same investor thesis: the supplement and wellness consumer has durably changed, and the brands that capture her at the intersection of beauty and health will outperform single-category players.

For you as an operator or investor in this space, the Imaraïs deal is a reference point. It prices celebrity dependency risk clearly, it confirms that mass retail placement changes your exit trajectory, and it shows that the ingestible beauty category has enough validation for an acquirer to commit $20 million at a moment when capital is selective.

The brands that understand these signals now are the ones that will position themselves for the next wave of consolidation rather than watch it happen from the outside.